Approval · Notice of Compliance 829 · 2002
VALCYTE: Notice of Compliance 829
Issued May 3, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 829
- Date
- May 3, 2002
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antiviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VALCYTE | 02245777 | Marketed |
Medicinal ingredients
- VALGANCICLOVIR HYDROCHLORIDE 450 MG per TAB